Thrombosis risk factors

Citations 51-60 of 164 total displayed.

Past content (since Dec 2000):

Clinician Update
Prevention of Venous Thromboembolism Among Hospitalized Medical Patients

Samuel Z. Goldhaber and Alexander G.G. Turpie
Circulation 2005;111:e1-3e, doi:10.1161/01.CIR.0000150393.51958.54 [Full text]  

Prevention of Venous Thromboembolism
Prevention of Recurrent Idiopathic Venous Thromboembolism

Samuel Z. Goldhaber
Circulation 2004;110:IV-20-24IV-, doi:10.1161/01.CIR.0000150641.65000.f2 [Abstract] [Full text]  

Vascular Medicine
Factor V^Leiden Inhibits Fibrinolysis In Vivo

Andrew C. Parker, Lakshmi V. Mundada, Alvin H. Schmaier, and William P. Fay
Circulation 2004;110:3594-3598; published online before print as doi:10.1161/01.CIR.0000148781.87906.C0 [Abstract] [Full text]  

Articles
Factor V^Leiden Inhibits Fibrinolysis In Vivo

Andrew C. Parker, Lakshmi V. Mundada, Alvin H. Schmaier, and William P. Fay
Circulation published November 29, 2004, doi:10.1161/01.CIR.0000148781.87906.C0 [Abstract]  

;:  

Cardiology Patient Pages
Prevention of Deep Vein Thrombosis and Pulmonary Embolism

Samuel Z. Goldhaber and John Fanikos
Circulation 2004;110:e445-447e, doi:10.1161/01.CIR.0000145141.70264.C5 [Full text]  

Arrhythmia/Electrophysiology
Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin

Brian F. Gage, Carl van Walraven, Lesly Pearce, Robert G. Hart, Peter J. Koudstaal, B.S.P. Boode, and Palle Petersen
Circulation 2004;110:2287-2292; published online before print as doi:10.1161/01.CIR.0000145172.55640.93 [Abstract] [Full text]  

Coronary Heart Disease
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes

J.P. Collet, G. Montalescot, B. Blanchet, M.L. Tanguy, J.L. Golmard, R. Choussat, F. Beygui, L. Payot, N. Vignolles, J.P. Metzger, and D. Thomas
Circulation 2004;110:2361-2367; published online before print as doi:10.1161/01.CIR.0000145171.89690.B4 [Abstract] [Full text]  

Articles
Selecting Patients With Atrial Fibrillation for Anticoagulation. Stroke Risk Stratification in Patients Taking Aspirin

Brian F. Gage, Carl van Walraven, Lesly Pearce, Robert G. Hart, Peter J. Koudstaal, B. S.P. Boode, and Palle Petersen
Circulation published October 11, 2004, doi:10.1161/01.CIR.0000145172.55640.93 [Abstract]  

Articles
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes

J. P. Collet, G. Montalescot, B. Blanchet, M. L. Tanguy, J. L. Golmard, R. Choussat, F. Beygui, L. Payot, N. Vignolles, J. P. Metzger, and D. Thomas
Circulation published October 11, 2004, doi:10.1161/01.CIR.0000145171.89690.B4 [Abstract]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17